Wistar-Led Team Awarded More Than $12 Million Grant from the NCI to Investigate Link Between Epstein-Barr Virus and Carcinomas
26 juil. 2023 10h21 HE
|
The Wistar Institute
PHILADELPHIA, PA, July 26, 2023 (GLOBE NEWSWIRE) -- It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its...
Wistar Scientists Discover Innate Tumor Suppression Mechanism
04 mai 2023 10h34 HE
|
The Wistar Institute
PHILADELPHIA, PA, May 04, 2023 (GLOBE NEWSWIRE) -- The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is...
Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir
30 mars 2023 10h07 HE
|
The Wistar Institute
PHILADELPHIA, March 30, 2023 (GLOBE NEWSWIRE) -- As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these...
Wistar Scientists Identify a Gene Signature to Assess Cancer Risk in People
06 févr. 2023 15h45 HE
|
The Wistar Institute
PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and...
Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy
19 janv. 2023 14h44 HE
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a...
Wistar Institute’s Maureen Murphy Named Deputy Director of the Ellen and Ronald Caplan Cancer Center
13 janv. 2023 09h18 HE
|
The Wistar Institute
PHILADELPHIA, PA, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Maureen Murphy, Ph.D., has been named Deputy Director of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute. Murphy will guide the...
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
07 juil. 2022 10h00 HE
|
The Wistar Institute
Philadelphia, PA, July 07, 2022 (GLOBE NEWSWIRE) -- PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical,...
The Wistar Institute Cancer Center to be Renamed with $10 Million Gift from Caplan Family to Advance Cancer Research
08 mars 2022 13h00 HE
|
The Wistar Institute
Philadelphia, March 08, 2022 (GLOBE NEWSWIRE) -- The Wistar Institute announces that Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to...
Wistar Reports New Class of Antibiotics Active Against a Wide Range of Bacteria
23 déc. 2020 11h23 HE
|
The Wistar Institute
PHILADLEPHIA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial...
DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, AstraZeneca, Penn, & Indiana University to Develop Innovative COVID-19 Treatment
15 déc. 2020 11h31 HE
|
The Wistar Institute
PHILADELPHIA, Dec. 15, 2020 (GLOBE NEWSWIRE) -- A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana...